Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only
curative option for myelodysplastic syndrome (MDS). However, relapse remains the primary …
Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasms
Published: 11/08/2024